Project
Ongoing
10 Members
A synthetic glycopeptide for anti-tumor immunotherapy: from design to first use in human
Sylvie Bay (PI)
Within the framework of developing a carbohydrate-based vaccine against cancer, we designed and prepared the MAG-Tn3, a fully synthetic immunogen based on the tumor-associated Tn antigen. The MAG-Tn3 is a glycopeptide associating Tn clusters […]